Disclosure of Risks and Uncertainties Are Especially Vital in Light of Regenerative Medicine

Author： Niemansburg S. L. Habets M. G. J. L. van Delden J. J. M. Bredenoord A. L.

ISSN： 1536-0075

Source： American Journal of Bioethics, Vol.14, Iss.4, 2014-04, pp. : 14-16

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Compounding Risks to Patients: Selective Disclosure is Not an Option

By McGoey Linsey

American Journal of Bioethics, Vol. 9, Iss. 8, 2009-08 ,pp. : 35-36

Routledge Ltd

Access to resources Recommend Favorite

New lines of GFP transgenic rats relevant for regenerative medicine and gene therapy

By Remy S.

Transgenic Research, Vol. 19, Iss. 5, 2010-10 ,pp. : 745-763

Springer Publishing Company

Access to resources Recommend Favorite

The osteochondral interface as a gradient tissue: From development to the fabrication of gradient scaffolds for regenerative medicine

Birth Defects Research. Part C: Embryo Today Reviews, Vol. 105, Iss. 1, 2015-03 ,pp. : 34-52

John Wiley & Sons Inc

Access to resources Recommend Favorite

Donation, Disclosure, and Deception

By Dresser Rebecca

American Journal of Bioethics, Vol. 1, Iss. 4, 2001-12 ,pp. : 15-16

Routledge Ltd

Access to resources Recommend Favorite

Precautionary Harm Disclosure in Clinical Trials

By Wu Kevin Chien-Chang

American Journal of Bioethics, Vol. 9, Iss. 8, 2009-08 ,pp. : 43-45

Routledge Ltd

Access to resources Recommend Favorite